Skip to main content

Advertisement

Table 2 Baseline characteristics of each group

From: Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation

  Early Obvious Severe
Age (years) 63 (57–74) 65 (48–75) 74 (63–76)
Cumulative dose (g) 730 (438–949) 1933 (584–4380) 1030 (890–1679)
Baseline vision 20/20–20/40 20/20–20/60 20/100–20/400
Follow-up (months) 13 (12–56) 36 (12–56) 14 (13–36)
  1. Median (range) reported for age, cumulative dose, and follow-up